Clover Health took a different approach to Medicare Advantage by building an AI platform that sits between the insurer and the physician. Founded in 2014 by Vivek Garipalli and Andrew Toy, the company created the Clover Assistant — a clinical decision support tool that surfaces relevant patient data, care gaps, and treatment recommendations during doctor visits without replacing the physician’s judgment.
The Clover Assistant pulls in claims data, lab results, pharmacy records, and social determinants of health to build a comprehensive picture of each patient. When a doctor opens the tool during a visit, it highlights things like missed screenings, potential drug interactions, and chronic condition management opportunities. Physicians who use it regularly show measurable improvements in care quality scores and diagnostic accuracy.
Clover went public through a SPAC merger in early 2021. The company serves over 100,000 Medicare Advantage members primarily in New Jersey, Georgia, Arizona, South Carolina, and several other states. Getting to profitability has been a grind — healthcare insurance is capital-intensive and regulatory complexity adds overhead. But Clover’s medical cost ratios have improved year over year, and the company has been licensing the Clover Assistant to other payers and providers through its Counterpart Health subsidiary. The team runs around 700 employees, with engineering talent split between Nashville and remote locations.
